City of Hope Receives $32.3 Million From the California Inst

Researchers at City of Hope were awarded $32.3 million from the CIRM to support three novel Phase 1 clinical trials evaluating innovative cell and gene therapy treatments for patients with HIV, acute myeloid leukemia and severe aplastic anemia.

Related Keywords

California , United States , University Of California San Diego , Karam Sandhu , Johnd Carpten , David Horne , John Baird , Paul Edmonds , Edith Miller , Defu Zeng , Ryotaro Nakamura , Joycelynne Palmer , Elizabeth Budde , Anthony Stein , Angelo Cardoso , Xiuli Wang , Aarond Miller , Johna Zaia , Morgan Helen Chu , Beckman Research Institute , Beckman Research Institute Of City Hope , Division Of Leukemia , Department Of Hematology Hematopoietic Cell Transplantation , Department Of Immunology Theranostics , Irell Manella Cancer Center , California Institute For Regenerative Medicine , Arthur Riggs Diabetes Metabolism Research Institute , California Institute , Regenerative Medicine , Research Institute , Manella Cancer Center Director , Distinguished Chair , Helen Chu Director , Beckman Research , Drug Administration Approved , Edith Miller Chair , Gene Therapy , California San , Hematopoietic Cell , Marissa Del Real , Arthur Riggs Diabetes , Metabolism Research Institute , Mace Siegel Professor , Hematopoietic Cell Transplantation , City Of Hope , News , Shiv , Aml , Severe Aplastic Anemia ,